196 related articles for article (PubMed ID: 31779149)
1. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
[TBL] [Abstract][Full Text] [Related]
5. A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity.
Gil A; Rodríguez-Escudero I; Stumpf M; Molina M; Cid VJ; Pulido R
PLoS One; 2015; 10(4):e0119287. PubMed ID: 25875300
[TBL] [Abstract][Full Text] [Related]
6. Structural Mechanisms of PTEN Regulation.
Masson GR; Williams RL
Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31636093
[TBL] [Abstract][Full Text] [Related]
7. Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast.
Cid VJ; Rodríguez-Escudero I; Andrés-Pons A; Romá-Mateo C; Gil A; den Hertog J; Molina M; Pulido R
Oncogene; 2008 Sep; 27(41):5431-42. PubMed ID: 18794878
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease.
Torices L; Mingo J; Rodríguez-Escudero I; Fernández-Acero T; Luna S; Nunes-Xavier CE; López JI; Mercadillo F; Currás M; Urioste M; Molina M; Cid VJ; Pulido R
Eur J Hum Genet; 2023 May; 31(5):568-577. PubMed ID: 36543932
[TBL] [Abstract][Full Text] [Related]
9. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
10. Fine-Tuning of Pten Localization and Phosphatase Activity Is Essential for Zebrafish Angiogenesis.
Stumpf M; Blokzijl-Franke S; den Hertog J
PLoS One; 2016; 11(5):e0154771. PubMed ID: 27138341
[TBL] [Abstract][Full Text] [Related]
11. A pathogenic role for germline PTEN variants which accumulate into the nucleus.
Mingo J; Rodríguez-Escudero I; Luna S; Fernández-Acero T; Amo L; Jonasson AR; Zori RT; López JI; Molina M; Cid VJ; Pulido R
Eur J Hum Genet; 2018 Aug; 26(8):1180-1187. PubMed ID: 29706633
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.
Gil A; Andrés-Pons A; Fernández E; Valiente M; Torres J; Cervera J; Pulido R
Mol Biol Cell; 2006 Sep; 17(9):4002-13. PubMed ID: 16807353
[TBL] [Abstract][Full Text] [Related]
13. Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L.
Johnston SB; Raines RT
PLoS One; 2015; 10(1):e0116898. PubMed ID: 25607987
[TBL] [Abstract][Full Text] [Related]
14. Yeast-based methods to assess PTEN phosphoinositide phosphatase activity in vivo.
Rodríguez-Escudero I; Fernández-Acero T; Bravo I; Leslie NR; Pulido R; Molina M; Cid VJ
Methods; 2015 May; 77-78():172-9. PubMed ID: 25448481
[TBL] [Abstract][Full Text] [Related]
15. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
16. PTEN hopping on the cell membrane is regulated via a positively-charged C2 domain.
Yasui M; Matsuoka S; Ueda M
PLoS Comput Biol; 2014 Sep; 10(9):e1003817. PubMed ID: 25211206
[TBL] [Abstract][Full Text] [Related]
17. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
[TBL] [Abstract][Full Text] [Related]
18. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ
Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903
[TBL] [Abstract][Full Text] [Related]
19. Regulation and modulation of PTEN activity.
Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
[TBL] [Abstract][Full Text] [Related]
20. The PTEN Tumor Suppressor Forms Homodimers in Solution.
Heinrich F; Chakravarthy S; Nanda H; Papa A; Pandolfi PP; Ross AH; Harishchandra RK; Gericke A; Lösche M
Structure; 2015 Oct; 23(10):1952-1957. PubMed ID: 26299948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
